A natural product-hybridization approach toward anticancer drug discovery: synthesis and antitumor evaluation of CTBC6, designed from sulforaphane and magnolol
Bioorganic Chemistry · 2026-06 · 173 · 109697
DOI: 10.1016/j.bioorg.2026.109697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-06. Verfasst von Cheng Tao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Natural Drugs Research and Development; The First Dongguan Affiliated Hospital and School of Pharmacy, Guangdo…. Hauptthemen laut MEDLINE: Isothiocyanates, Sulfoxides, Antineoplastic Agents, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Natural products, with their promising drug-like profiles, inherent pharmacological potential, and a vast reservoir of privileged structures, have long been recognized as a rich source of hit compounds in anticancer drug discovery. Building upon our group's prior work, this study delves into the medicinal chemistry of sulforaphane (SFN)-a star molecule in anticancer research, leading to the discovery of CTBC6 as a novel small molecule anticancer compound. We demonstrated that CTBC6 exhibited potent anti-breast cancer effects both in vitro and in vivo with no significant organ toxicity. We investigated the anti-breast cancer function of the hit hybrid compound CTBC6, and found that CTBC6 induced apoptosis and caused cell cycle arrest at the G2/M phase, while also effectively suppressing cell migration. Moreover, transcriptome analysis and the mechanistic studies revealed that CTBC6 may impede breast cancer progression by inhibiting MEK/ERK signaling pathway. Importantly, the functional targets of CTBC6 in breast cancer was assessed. Through chemical proteomics, we identified CNOT10 and STAT5A as potential direct targets through which CTBC6 exerts its anti-breast cancer activity. Our study lays a good foundation for further medical research of sulforaphane and its derivatives, and also presents a new strategic paradigm for natural product-driven anticancer drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Natural Drugs Research and Development; The First Dongguan Affiliated Hospital and School of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Medical University, Dongguan 523808, China.
- Department of Pathology, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan 523808, China.
- Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Peking University Shenzhen Hospital, Shenzhen 518036, China.
- Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dongguan 523808, PR China. Electronic address: Xiejj0816@gdmu.edu.cn.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Medical University, Dongguan 523808, China. Electronic address: pengjy@gdmu.edu.cn.
Förderung
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Tao, C., Chen, M., Liu, B., Chen, H., Ji, F., Huang, J., Chen, J., Guo, Y., Liu, X., Yuan, H., Feng, Y., Li, Z., Cheng, Y., Luo, D., Wu, D., Lin, X., Xie, J., Peng, J., & Chen, Z. (2026). A natural product-hybridization approach toward anticancer drug discovery: synthesis and antitumor evaluation of CTBC6, designed from sulforaphane and magnolol. Bioorganic Chemistry, 173, 109697. https://doi.org/10.1016/j.bioorg.2026.109697
Vancouver
Tao C, Chen M, Liu B, Chen H, Ji F, Huang J, et al. A natural product-hybridization approach toward anticancer drug discovery: synthesis and antitumor evaluation of CTBC6, designed from sulforaphane and magnolol. Bioorganic Chemistry. 2026;173:109697. doi:10.1016/j.bioorg.2026.109697
BibTeX
@article{Tao2026,
author = {Tao, Cheng and Chen, Mingxing and Liu, Bing and Chen, Haoxiong and Ji, Fangyuan and Huang, Junchang and Chen, Junhong and Guo, Yishan and Liu, Xueyi and Yuan, Huiling and Feng, Yuanlong and Li, Zimin and Cheng, Ying and Luo, Daqiang and Wu, Dudu and Lin, Xian and Xie, Jianjun and Peng, Jiangyun and Chen, Zhi},
title = {A natural product-hybridization approach toward anticancer drug discovery: synthesis and antitumor evaluation of CTBC6, designed from sulforaphane and magnolol},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {173},
pages = {109697},
doi = {10.1016/j.bioorg.2026.109697}
}
EUVIMED